Assembly Biosciences, Inc.
Assembly Biosciences, Inc.（ASMB）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ASMB · 截至 2026年6月8日
活动摘要
买入笔数
3
P-Purchase only
卖出笔数
4
近12个月
买卖比
0.75
Buy/Sell (by trades)
整体情绪
Assembly Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ASMB 季度内部人买卖趋势
ASMB 内幕交易卖出 · ASMB 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ASMB CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ASMB 高管卖出股份 · ASMB 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 29, 2026 | Gaggar Anuj Chief Medical Officer | Award | 14,000 | — | Form 4 |
| Mar 29, 2026 | White Nicole S Chief Manufacturing Officer | Award | 14,000 | — | Form 4 |
| Mar 29, 2026 | Bjorkquist Jeanette M PFO and PAO | Award | 3,500 | — | Form 4 |
| Mar 29, 2026 | Delaney William E IV Chief Scientific Officer | Award | 14,000 | — | Form 4 |
| Mar 29, 2026 | Okazaki Jason A CEO and President · Director | Award | 50,750 | — | Form 4 |
| May 26, 2026 | GILEAD SCIENCES, INC. 10 percent owner | Award | 471,698 | $12.50M⚡ | Form 4 |
| Mar 29, 2026 | Bjorkquist Jeanette M PFO and PAO | Award | 6,500 | — | Form 4 |
| Mar 30, 2026 | Bjorkquist Jeanette M PFO and PAO | Sale | 312 | $8K | Form 4 |
| Mar 30, 2026 | Bjorkquist Jeanette M PFO and PAO | Sale | 16 | $440 | Form 4 |
| Mar 29, 2026 | White Nicole S Chief Manufacturing Officer | Award | 26,000 | — | Form 4 |
| Mar 30, 2026 | White Nicole S Chief Manufacturing Officer | Sale | 188 | $5K | Form 4 |
| Mar 30, 2026 | White Nicole S Chief Manufacturing Officer | Sale | 9 | $247 | Form 4 |
| Mar 29, 2026 | Gaggar Anuj Chief Medical Officer | Award | 26,000 | — | Form 4 |
| Mar 29, 2026 | Delaney William E IV Chief Scientific Officer | Award | 26,000 | — | Form 4 |
| Mar 29, 2026 | Okazaki Jason A CEO and President · Director | Award | 94,250 | — | Form 4 |
| Aug 8, 2025 | GILEAD SCIENCES, INC. 10 percent owner | Purchase | 2,295,920 | $2K | Form 4 |
| Jun 16, 2025 | Bjorkquist Jeanette M PFO and PAO | Award | 300 | — | Form 4 |
| Mar 31, 2025 | McHutchison John G Director | Sale | 757 | $7K | Form 4 |
| Mar 29, 2025 | Bjorkquist Jeanette M PAO | Award | 1,655 | — | Form 4 |
| Mar 31, 2025 | Bjorkquist Jeanette M PAO | Sale | 180 | $2K | Form 4 |
| Mar 31, 2025 | Okazaki Jason A CEO and President · Director | Sale | 355 | $3K | Form 4 |
| Mar 31, 2025 | White Nicole S Chief Manufacturing Officer | Sale | 197 | $2K | Form 4 |
| Dec 30, 2024 | Houghton Michael Director | Purchase | 3,202 | $50K | Form 4 |
| Dec 19, 2024 | GILEAD SCIENCES, INC. 10 percent owner | Purchase | 940,499 | $20.10M⚡ | Form 4 |
| Nov 25, 2024 | Schornstein Alexander 10 percent owner | Purchase | 5,000 | $74K | Form 4 |
GILEAD SCIENCES, INC.
10 percent owner
日期
May 26
股数
471,698
均价
$26.50
总金额
$12.50M ⚡
GILEAD SCIENCES, INC.
10 percent owner
日期
Dec 19
股数
940,499
均价
$21.37
总金额
$20.10M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ASMB 内幕交易
ASMB 内幕交易
Assembly Biosciences, Inc.（ASMB）内幕交易数据来源于公司内部人（包括Bjorkquist Jeanette M (PFO and PAO), White Nicole S (Chief Manufacturing Officer), Gaggar Anuj (Chief Medical Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ASMB内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Assembly Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ASMB 内幕交易 · 5个问题Assembly Biosciences, Inc.（ASMB）的内部人包括高管和董事，如Bjorkquist Jeanette M (PFO and PAO), White Nicole S (Chief Manufacturing Officer), Gaggar Anuj (Chief Medical Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026